Whitehawk Therapeutics, Inc.
WHWK- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001422142
No open-market purchases or sales by Whitehawk Therapeutics, Inc. insiders were filed in the last 90 days; 77 institutions reported holding it in 13F filings for Q2 2026, worth $198.0M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Whitehawk Therapeutics, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 65 | 1 | 52 | −12 |
| Shares | 11.5M | 320.2K | 12.0M | +824.2K (+7.4%) |
| Value | $16.7M | $467.6K | $24.7M | +$8.39M (+51.5%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (10)
Institutions that held Whitehawk Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BML Capital Management, LLC | 2,000,000 | $4.12M | 2.42% |
| EcoR1 Capital, LLC | 1,845,253 | $3.80M | 0.13% |
| BlackRock, Inc. | 242,888 | $500.3K | 0.00% |
| Bridgeway Capital Management, LLC | 93,300 | $192.2K | 0.00% |
| Affinity Asset Advisors, LLC | 47,019 | $96.9K | 0.02% |
| Prudential Financial Inc | 26,400 | $54.4K | 0.00% |
| Two Sigma Investments, LP | 16,917 | $34.8K | 0.00% |
| XTX Topco Ltd | 15,591 | $32.1K | 0.00% |
| Man Group plc | 14,495 | $29.9K | 0.00% |
| Russell Investments Group, Ltd. | 1,512 | $3.12K | 0.00% |
Sold out (22)
Institutions that held Whitehawk Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Vivo Capital, LLC | 509,572 | $744.0K |
| Goldman Sachs Group Inc | 154,270 | $225.2K |
| Verition Fund Management LLC | 82,361 | $120.2K |
| 683 Capital Management, LLC | 80,000 | $116.8K |
| Y-Intercept (Hong Kong) Ltd | 48,960 | $71.5K |
| Centiva Capital, LP | 33,100 | $48.3K |
| HRT Financial LP | 28,172 | $41.0K |
| Virtu Financial LLC | 27,580 | $40.0K |
| Paloma Partners Management Co | 19,019 | $27.8K |
| D. E. Shaw & Co., Inc. | 17,796 | $26.0K |
| SEI Investments Co | 15,749 | $23.0K |
| Qube Research & Technologies Ltd | 12,071 | $17.6K |
| Rhumbline Advisers | 9,487 | $13.8K |
| Mirae Asset Global ETFs Holdings Ltd. | 8,135 | $11.9K |
| Public Employees Retirement System of Ohio | 943 | $1.38K |
| Macquarie Group Ltd | 830 | $1.21K |
| Royal Bank of Canada | 917 | $1.00K |
| The PNC Financial Services Group, Inc. | 368 | $537 |
| New York State Common Retirement Fund | 141 | $206 |
| Nisa Investment Advisors, LLC | 131 | $191 |
| Farther Finance Advisors, LLC | 54 | $77 |
| Barclays PLC | 8 | $11 |
Not filed for Q3 2024 yet (1)
Institutions that held Whitehawk Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 320,247 | $467.6K |